Drug Trial Radar · NCT07517263
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
5,700
Planned (sponsor's estimate)
Start
May 11, 2026
Primary completion
Jan 9, 2030
Study completion Jan 9, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Apr 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open-label extension study provides post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301). Study has been terminated by sponsor following the outcome of the Lp(a)HORIZON study (NCT04023552), which did not meet its primary endpoint.
Conditions
- Cardiovascular Disease and Lipoprotein(a)
Interventions
Pelacarsen (TQJ230)Drug
pelacarsen 80mg s.c. monthly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Adverse eventsTime frame: Up to 36 months
Locations
646 sites in 40 countries. Site status is shown where the registry gives one.
SEC Clinical Research LLC
Andalusia, Alabama
Heart Center Research Llc
Huntsville, Alabama
Mobile Heart Specialists
Mobile, Alabama
Mercy Gilbert Medical Center
Gilbert, Arizona
Clinical Research Inst of Arizona
Sun City West, Arizona
Eclipse Clinical Research
Tucson, Arizona
Cardiology and Medicine Clinic PA
Little Rock, Arkansas
Cardiovascular Res Found
Beverly Hills, California
National Heart Institute
Beverly Hills, California
Valley Clinical Trials Inc
Covina, California
Diabetes Lipid Management Center
Huntington Beach, California
University of Calif Irvine Med Cntr
Irvine, California
Memorial Care Health System
Long Beach, California
Keck Medical Center USC
Los Angeles, California
Valley Clinical Trials
Northridge, California
Stanford University Medical Center
Palo Alto, California
University of California San Diego
San Diego, California
UCSF
San Francisco, California
Manshadi Heart Institute
Stockton, California
Interv Cardiology Med Grp
West Hills, California
Univ Of Color Anschutz Med Center
Aurora, Colorado
Bridgeport Hospital
Bridgeport, Connecticut
Hartford Hospital
Hartford, Connecticut
Chase Medical Research LLC
Waterbury, Connecticut
Excel Medical Clinical Trials LLC
Boca Raton, Florida
Bay Area Cardiology Assoc
Brandon, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Advanced Research for Health Improvement LLC
Naples, Florida
Peace River Cardiovascular Center
Port Charlotte, Florida
Progressive Medical Research
Port Orange, Florida
East Coast Inst for Research LLC
Saint Augustine, Florida
Cardiology Partners Clinical Research Institute
Wellington, Florida
Piedmont Heart Institute
Atlanta, Georgia
Emory University
Atlanta, Georgia
Cardiovascular Consultants of S GA
Thomasville, Georgia
Rush University Medical Center
Chicago, Illinois
Advocate Lutheran General Childrens Hospital
Park Ridge, Illinois
Krannert Institute of Cardiology
Indianapolis, Indiana
Uni Of Iowa Hospitals And Clinics
Iowa City, Iowa
University of Kansas Hospital
Kansas City, Kansas
Showing 40 of 646 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.